Brookfield Corp’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-168,457
Closed -$2.45M 711
2023
Q1
$2.45M Buy
+168,457
New +$3.02M 0.01% 398
2022
Q4
Sell
-33,139
Closed -$799K 696
2022
Q3
$799K Sell
33,139
-29,690
-47% -$915K ﹤0.01% 555
2022
Q2
$1.98M Sell
62,829
-6,989
-10% -$253K 0.01% 412
2022
Q1
$3.07M Sell
69,818
-3,677
-5% -$158K 0.01% 335
2021
Q4
$3.2M Buy
+73,495
New +$2.88M 0.01% 277
2021
Q1
Sell
-18,038
Closed -$488K 530
2020
Q4
$488K Buy
+18,038
New +$464K ﹤0.01% 411

Other funds holding ACH

Brookfield Corp's ACH Position: Q2 2023 in Review

Brookfield Corp sold out of Accendra Health (ACH) in Q2 2023, closing a stake of 168,457 shares — an estimated $2.45M sold.

Brookfield Corp first reported a position in ACH in Q4 2020 and held it in 6 quarters. The position peaked at $3.2M in Q4 2021. 230 funds tracked by Wall St. Rank hold ACH as of Q2 2023.

  • Brookfield Corp reported no remaining Accendra Health position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 168,457 Accendra Health shares in Q2 2023, an estimated $2.45M.
  • Brookfield Corp first reported a position in Accendra Health in Q4 2020 and held it in 6 quarters.
  • Brookfield Corp's Accendra Health position peaked at $3.2M in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.